These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 9390015
1. Adaptation of parathyroid function to intravenous 1,25-dihydroxyvitamin D3 or partial parathyroidectomy in normal dogs. Cloutier M, Gagnon Y, Gascon-Barré M, Brossard JH, D'Amour P. J Endocrinol; 1997 Oct; 155(1):133-41. PubMed ID: 9390015 [Abstract] [Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
3. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH. Szabó A, Schmutz A, Pesian S, Schmidt-Gayk H, Ritz E, Reichel H. Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444 [Abstract] [Full Text] [Related]
4. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays. Brandi L, Egfjord M, Olgaard K. Nephron Clin Pract; 2005 Feb; 99(4):c128-37. PubMed ID: 15722644 [Abstract] [Full Text] [Related]
5. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. Galceran T, Martin KJ, Morrissey JJ, Slatopolsky E. Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963 [Abstract] [Full Text] [Related]
6. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Takahashi F, Finch JL, Denda M, Dusso AS, Brown AJ, Slatopolsky E. Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408 [Abstract] [Full Text] [Related]
7. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. Brown AJ, Ritter C, Slatopolsky E, Muralidharan KR, Okamura WH, Reddy GS. J Cell Biochem; 1999 Apr 01; 73(1):106-13. PubMed ID: 10088729 [Abstract] [Full Text] [Related]
8. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. Weisinger JR, Favus MJ, Langman CB, Bushinsky DA. J Bone Miner Res; 1989 Dec 01; 4(6):929-35. PubMed ID: 2610024 [Abstract] [Full Text] [Related]
9. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells. Imanishi Y, Inaba M, Seki H, Koyama H, Nishizawa Y, Morii H, Otani S. J Steroid Biochem Mol Biol; 1999 Dec 01; 70(4-6):243-8. PubMed ID: 10622414 [Abstract] [Full Text] [Related]
10. Lack of involution of hyperplastic parathyroid glands in dogs: adaptation via a decrease in the calcium stimulation set point and a change in secretion profile. Cloutier M, Brossard JH, Gascon-Barré M, D'Amour P. J Bone Miner Res; 1994 May 01; 9(5):621-9. PubMed ID: 8053390 [Abstract] [Full Text] [Related]
11. Low calcium diet in dogs causes a greater increase in parathyroid function measured with an intact hormone than with a carboxylterminal assay. Cloutier M, D'Amour P, Gascon-Barré M, Hamel L. Bone Miner; 1990 Jun 01; 9(3):179-88. PubMed ID: 2114188 [Abstract] [Full Text] [Related]
12. Lack of influence of 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion from normal or hyperplastic glands. Rothstein M, Olgaard K, Arbelaez M, Finco D, Klahr S, Slatopolsky E. Calcif Tissue Int; 1983 Jul 01; 35(4-5):449-54. PubMed ID: 6604566 [Abstract] [Full Text] [Related]
13. Vitamin D metabolites do not alter parathyroid hormone secretion acutely. Magliola L, Anast CS, Forte LR. Bone Miner; 1986 Dec 01; 1(6):495-505. PubMed ID: 3509783 [Abstract] [Full Text] [Related]
14. Immunological evidences for post-translational control of the parathyroid function by ionized calcium in dogs. Cloutier M, Rousseau L, Gascon-Barré M, D'Amour P. Bone Miner; 1993 Sep 01; 22(3):197-207. PubMed ID: 8268753 [Abstract] [Full Text] [Related]
15. Functional evidence for two types of parathyroid adenoma. D'Amour P, Weisnagel J, Brossard JH, Ste-Marie LG, Rousseau L, Lepage R. Clin Endocrinol (Oxf); 1998 May 01; 48(5):593-601. PubMed ID: 9666871 [Abstract] [Full Text] [Related]
16. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency. Soliman E, Canaff L, Fox J, Hendy GN. Endocrinology; 1997 Jun 01; 138(6):2596-600. PubMed ID: 9165053 [Abstract] [Full Text] [Related]
17. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC, Quach HP, Vieth R, Pang KS. Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451 [Abstract] [Full Text] [Related]
18. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E. Endocrinology; 1995 Apr 01; 136(4):1419-25. PubMed ID: 7895652 [Abstract] [Full Text] [Related]
19. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia. Funahashi H, Tanaka Y, Imai T, Wada M, Tsukamura K, Hayakawa Y, Matsuura N, Kikumori T, Oiwa M, Tominaga Y, Takagi H. J Endocrinol Invest; 1998 Jan 01; 21(1):43-7. PubMed ID: 9633022 [Abstract] [Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Cantley LK, Russell J, Lettieri D, Sherwood LM. Endocrinology; 1985 Nov 01; 117(5):2114-9. PubMed ID: 3840080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]